Review article: ulcerative colitis, smoking and nicotine therapy
Review article: associations between immune activation, intestinal permeability and the irritable bowel syndrome
Impact of Clostridium difficile colitis on 5-year health outcomes in patients with ulcerative colitis
Does co-treatment with immunosuppressors improve outcome in patients with Crohn's disease treated with adalimumab?
Myelosuppression monitoring after immunomodulator initiation in veterans with inflammatory bowel disease: a national practice audit
Assessment of non-alcoholic fatty liver disease using serum total cell death and apoptosis markers
Treatment of gastric carcinoids type 1 with the gastrin receptor antagonist netazepide (YF476) results in regression of tumours and normalisation of serum chromogranin A
Helicobacter pylori eradication in Western Australia using novel quadruple therapy combinations
Rifaximin treatment for the irritable bowel syndrome with a positive lactulose hydrogen breath test improves symptoms for at least 3 months
Commentary: PPIs and risk of serious infection in decompensated cirrhosis
Commentary: PPIs and risk of serious infection in decompensated cirrhosis – authors' reply
Commentary: predicting response to ciclosporin in acute severe ulcerative colitis
Commentary: predicting response to ciclosporin in acute severe ulcerative colitis – authors' reply
Commentary: physical activity and NAFLD – cause or effect?
Commentary: physical activity and NAFLD - cause or effect? Authors' reply
Commentary: psychological disorders linked to functional dyspepsia
Commentary: psychological disorders linked to functional dyspepsia – authors' reply
Commentary: the link between community-acquired pneumonia and PPI use
Letter: surveillance of Helicobacter pylori antibiotic resistance
Letter: surveillance of Helicobacter pylori antibiotic resistance – authors' reply
Letter: vaptans for the treatment of hyponatraemia and ascites in patients with cirrhosis
Letter: vaptans for the treatment of hyponatraemia and ascites in patients with cirrhosis – authors’ reply
Letter: potential chemopreventive effects of statins in oesophageal adenocarcinoma
Letter: potential chemopreventive effects of statins in oesophageal adenocarcinoma – authors' reply
Letter: the effects of preoperative infliximab on complications after surgery for ulcerative colitis
Letter: the effects of preoperative infliximab on complications after surgery for ulcerative colitis – authors' reply
Corrigenda
Corrigenda